BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy

Blood Cancer J. 2011 Jul;1(7):e30. doi: 10.1038/bcj.2011.26. Epub 2011 Jul 22.
No abstract available